CXCL12 and TP53 genetic polymorphisms as markers of susceptibility in a Brazilian children population with acute lymphoblastic leukemia (ALL)

[1]  J. Rey,et al.  Prognostic value of the TP53 Arg72Pro single-nucleotide polymorphism and susceptibility to medulloblastoma in a cohort of Brazilian patients , 2012, Journal of Neuro-Oncology.

[2]  L. Guillo,et al.  TP53 codon 72 polymorphism in pigmentary phenotypes , 2012, Journal of Biosciences.

[3]  Yao Liu,et al.  P53 codon 72 polymorphism and colorectal cancer: a meta-analysis of epidemiological studies. , 2011, Hepato-gastroenterology.

[4]  B. Horta,et al.  TP53 gene polymorphism: Importance to cancer, ethnicity and birth weight in a Brazilian cohort , 2011, Journal of Biosciences.

[5]  M. Rafeek,et al.  P53 gene polymorphisms and breast cancer risk in Arab women , 2011, Medical oncology.

[6]  J. Voltarelli,et al.  CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients. , 2011, Cytokine.

[7]  C. Graux.  Biology of acute lymphoblastic leukemia (ALL): clinical and therapeutic relevance. , 2011, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[8]  D. Banerjee,et al.  Chemokines at the crossroads of tumor‐fibroblast interactions that promote malignancy , 2011, Journal of leukocyte biology.

[9]  Claire Schwab,et al.  Acute lymphoblastic leukaemia. , 2011, Methods in molecular biology.

[10]  Olivia Fletcher,et al.  Architecture of inherited susceptibility to common cancer , 2010, Nature Reviews Cancer.

[11]  Magali Olivier,et al.  TP53 mutations in human cancers: origins, consequences, and clinical use. , 2010, Cold Spring Harbor perspectives in biology.

[12]  M. T. Dorak,et al.  TP53 R72P and MDM2 SNP309 polymorphisms in modification of childhood acute lymphoblastic leukemia susceptibility. , 2009, Cancer genetics and cytogenetics.

[13]  M. Aoki,et al.  CCR5 and p53 codon 72 gene polymorphisms: implications in breast cancer development. , 2009, International journal of molecular medicine.

[14]  J. Voltarelli,et al.  CXCL12 rs1801157 polymorphism in patients with breast cancer, hodgkin's lymphoma, and non‐hodgkin's lymphoma , 2009, Journal of clinical laboratory analysis.

[15]  R. Kalluri,et al.  Contribution of bone microenvironment to leukemogenesis and leukemia progression , 2009, Leukemia.

[16]  Karen H. Vousden,et al.  p53 in health and disease , 2007, Nature Reviews Molecular Cell Biology.

[17]  A. Holmes,et al.  Risk Factors for Acute Leukemia in Children: A Review , 2006, Environmental health perspectives.

[18]  M. Fungaro,et al.  Stromal cell‐derived factor‐1 chemokine gene variant in blood donors and chronic myelogenous leukemia patients , 2007, Journal of clinical laboratory analysis.

[19]  M. Oren,et al.  p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts. , 2006, Cancer research.

[20]  M. Olivier,et al.  TP53 mutations as biomarkers for cancer epidemiology in Latin America: current knowledge and perspectives. , 2005, Mutation research.

[21]  Cheng Cheng,et al.  Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. , 2004, Blood.

[22]  D. Covas,et al.  Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil. , 2004, Blood cells, molecules & diseases.

[23]  Mariela Granero Farias,et al.  Diagnóstico laboratorial das leucemias linfóides agudas , 2004 .

[24]  Xin Lu,et al.  Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.

[25]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[26]  C. Felix,et al.  Pediatric Acute Lymphoblastic Leukemia: Challenges and Controversies in 2000. , 2000, Hematology. American Society of Hematology. Education Program.

[27]  Pui Ch.  Childhood leukemias--current status and future perspective. , 1995 .

[28]  C. Pui.  Childhood leukemias--current status and future perspective. , 1995, Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui.

[29]  D. Pim,et al.  Primary structure polymorphism at amino acid residue 72 of human p53 , 1987, Molecular and cellular biology.